Intuitive Surgical (NASDAQ:ISRG) Rating Lowered to Hold at BidaskClub

Intuitive Surgical (NASDAQ:ISRG) was downgraded by stock analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, BidAskClub reports.

A number of other research firms have also commented on ISRG. UBS Group set a $560.00 price objective on Intuitive Surgical and gave the stock a “hold” rating in a research note on Friday, July 19th. Northland Securities set a $375.00 price objective on Intuitive Surgical and gave the stock a “sell” rating in a research note on Friday, July 19th. ValuEngine lowered Intuitive Surgical from a “hold” rating to a “sell” rating in a research note on Friday, July 12th. Piper Jaffray Companies lifted their price objective on Intuitive Surgical from $610.00 to $633.00 and gave the stock an “overweight” rating in a research note on Friday, July 19th. Finally, Canaccord Genuity reiterated a “buy” rating and issued a $610.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research note on Friday, July 19th. Three investment analysts have rated the stock with a sell rating, four have assigned a hold rating and eight have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $575.33.

Shares of Intuitive Surgical stock traded up $1.07 during trading on Wednesday, reaching $524.19. The company’s stock had a trading volume of 8,200 shares, compared to its average volume of 594,557. The business’s fifty day moving average price is $508.23 and its 200-day moving average price is $522.18. The firm has a market cap of $60.46 billion, a price-to-earnings ratio of 55.46, a price-to-earnings-growth ratio of 3.89 and a beta of 1.13. Intuitive Surgical has a one year low of $430.24 and a one year high of $589.32.



Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $3.25 EPS for the quarter, topping analysts’ consensus estimates of $2.23 by $1.02. The business had revenue of $1.10 billion for the quarter, compared to analyst estimates of $1.03 billion. Intuitive Surgical had a return on equity of 17.35% and a net margin of 29.95%. The firm’s revenue for the quarter was up 20.9% on a year-over-year basis. During the same period in the previous year, the company posted $2.76 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical will post 10.12 EPS for the current fiscal year.

In related news, VP Jamie Samath sold 259 shares of the business’s stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $532.14, for a total transaction of $137,824.26. Following the transaction, the vice president now directly owns 277 shares in the company, valued at $147,402.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Curet Myriam sold 4,974 shares of the business’s stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $532.14, for a total value of $2,646,864.36. Following the transaction, the executive vice president now owns 3,851 shares in the company, valued at $2,049,271.14. The disclosure for this sale can be found here. Insiders have sold 25,869 shares of company stock worth $13,664,252 over the last 90 days. Corporate insiders own 1.70% of the company’s stock.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its stake in shares of Intuitive Surgical by 27.4% in the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 28,879 shares of the medical equipment provider’s stock valued at $15,148,000 after purchasing an additional 6,208 shares during the period. Stonehage Fleming Financial Services Holdings Ltd bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at approximately $84,805,000. EP Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 40.6% in the 2nd quarter. EP Wealth Advisors LLC now owns 1,809 shares of the medical equipment provider’s stock valued at $949,000 after purchasing an additional 522 shares during the period. Toronto Dominion Bank grew its stake in shares of Intuitive Surgical by 40.6% in the 2nd quarter. Toronto Dominion Bank now owns 112,983 shares of the medical equipment provider’s stock valued at $59,254,000 after purchasing an additional 32,642 shares during the period. Finally, Atria Investments LLC grew its stake in shares of Intuitive Surgical by 10.4% in the 2nd quarter. Atria Investments LLC now owns 1,689 shares of the medical equipment provider’s stock valued at $864,000 after purchasing an additional 159 shares during the period. Hedge funds and other institutional investors own 85.97% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Featured Story: How do taxes affect a CDs total return?

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.